What is Opus Genetics's accrued expenses?

Opus Genetics (IRD) reported accrued expenses of $795K in Q1 2026.

How has Opus Genetics's accrued expenses changed year-over-year?

Opus Genetics's accrued expenses increased by 54.4% year-over-year, from $515K to $795K.

What is the long-term trend for Opus Genetics's accrued expenses?

Over 5 years (2020 to 2025), Opus Genetics's accrued expenses has grown at a 0.2% compound annual growth rate (CAGR), from $1.97M to $1.99M.

What does accrued expenses mean?

Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Opus Genetics IRD Accrued Expenses

Accrued Expenses at other companies

MeiraGTx Holdings plcMGTX

$105.11M+18,022%

4D Molecular TherapeuticsFDMT

$22.87M+41.1%

Opko HealthOPK

$83.48M-26.3%

Kodiak Sciences IncKOD

$26.57M+98.5%

Prime MedicinePRME

$2.19M-47.6%

Candel Therapeutics, Inc.CADL

$89K-96.7%

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's accrued expenses?: Opus Genetics (IRD) reported accrued expenses of $795K in Q1 2026.
How has Opus Genetics's accrued expenses changed year-over-year?: Opus Genetics's accrued expenses increased by 54.4% year-over-year, from $515K to $795K.
What is the long-term trend for Opus Genetics's accrued expenses?: Over 5 years (2020 to 2025), Opus Genetics's accrued expenses has grown at a 0.2% compound annual growth rate (CAGR), from $1.97M to $1.99M.
What does accrued expenses mean?: Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.